Castle Biosciences CSTL Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Castle Biosciences’s reported figures.
Based on the most recent quarter.
The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Castle Biosciences's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Castle Biosciences's quick ratio?
- Castle Biosciences (CSTL) reported quick ratio of 6.5× in Q1 2026.
- How has Castle Biosciences's quick ratio changed year-over-year?
- Castle Biosciences's quick ratio decreased by 28.9% year-over-year, from 9.2× to 6.5×.
- What is the long-term trend for Castle Biosciences's quick ratio?
- Over 5 years (2020 to 2025), Castle Biosciences's quick ratio has grown at a -24.2% compound annual growth rate (CAGR), from 20.5× to 5.1×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.